Current status: 1125 hESC lines, 7770 hiPSC lines, and 205 clinical studies, and 2402 certificates
Monthly statistic from Apr 1, 2026
Posted on April 1, 2026
| total lines | 8895 |
| hESC lines | 1125 |
| hiPSC lines | 7770 |
| derivation countries | 52 |
| projects | 340 |
| providers | 1043 |
| clinical studies | 205 |
| subclones | 3995 |
| certificates | 2402 |
| cell line certificates | 2246 |
| project certificates | 156 |